Clinical Pathway Development Lacks Patient Input, White Paper Says
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA says the finding that patients' views are not considered when providers and payers develop pathways to standardize treatment, most commonly in oncology, is "eye opening."